Kevin M. Ban - 18 Nov 2022 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Role
EVP, Chief Medical Officer
Signature
/s/ Kevin M. Ban by Cherita Thomas, Attorney-in-Fact
Issuer symbol
WBA
Transactions as of
18 Nov 2022
Net transactions value
-$63,394
Form type
4
Filing time
22 Nov 2022, 19:20:54 UTC
Previous filing
03 Nov 2022
Next filing
27 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WBA Common Stock Options Exercise $350,714 +10,303 +37% $34.04 38,219 18 Nov 2022 Direct F1
transaction WBA Common Stock Sale $414,108 -10,303 -27% $40.19 27,916 18 Nov 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WBA Employee Stock Option (Right to Buy) Options Exercise $0 -10,303 -67% $0.000000 5,167 18 Nov 2022 Common Stock 10,303 $34.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares underlying restricted stock units issued in lieu of dividends (through November 15, 2022) on outstanding restricted stock units.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.19 to $40.22, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.
F3 The option, representing a right to purchase a total of 15,470 shares, became exercisable with respect to 5,151 shares on November 1, 2021, and with respect to 5,152 shares on November 1, 2022.